During the past decade, Albury Wodonga Regional Cancer Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albury Wodonga Regional Cancer Centre" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Albury Wodonga Regional Cancer Centre" are "First Line Non-Small Cell Lung Cancer" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "Albury Wodonga Regional Cancer Centre" in a lesser frequency.

Most popular intervention types in "Albury Wodonga Regional Cancer Centre" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Avelumab Weekly" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Albury Wodonga Regional Cancer Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Albury Wodonga Regional Cancer Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Albury Wodonga Regional Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Albury Wodonga Regional Cancer Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".